NLS Pharmaceutics AG Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.58 | $1.58 | $1.58 |
| Q2 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 1 | $1.54 | $1.54 | $1.54 |
NLS Pharmaceutics AG Earnings Date And Information
NLS Pharmaceutics AG last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. NLS Pharmaceutics AG has generated $0 earnings per share over the last year ($-0.32 diluted earnings per share) and currently has a price-to-earnings ratio of -79.76. NLS Pharmaceutics AG has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
NLS Pharmaceutics AG Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/18/2024 | Q2 2024 | -$0.05 | $0 | $0 | ||
| 05/15/2024 | Q4 2023 | -$0.14 | $0 | $0 | ||
| 06/29/2023 | Q2 2023 | -$0.20 | $0 | |||
| 05/05/2023 | Q4 2022 | -$0.29 | $0 | |||
| 10/11/2022 | Q2 2022 | -$0.54 | $0 | |||
| 03/24/2022 | Q4 2021 | -$0.50 | $0 | |||
| 09/28/2021 | Q2 2021 | -$0.42 | $0 | |||
| 05/14/2021 | Q4 2020 | -$0.34 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.11 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.18 | $0 | |||
| 06/29/2019 | Q2 2019 | -$0.31 | $0 | |||
| 12/30/2018 | Q4 2018 | -$0.28 | $0 | |||
| 06/29/2018 | Q2 2018 | -$0.19 | $0 | |||
| 03/30/2018 | Q1 2018 | -$0.12 | $0 | |||
| 06/29/2017 | Q2 2017 | -$0.16 | $0 | |||
| 03/30/2017 | Q1 2017 | -$0.16 | $0 |
NLS Pharmaceutics AG Earnings: Frequently Asked Questions
-
When is NLS Pharmaceutics AG's earnings date?
NLS Pharmaceutics AG has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
-
How can I listen to NLS Pharmaceutics AG's earnings conference call?
The conference call for NLS Pharmaceutics AG's latest earnings report can be listened to online.
-
How can I read NLS Pharmaceutics AG's conference call transcript?
The conference call transcript for NLS Pharmaceutics AG's latest earnings report can be read online.
-
How much profit does NLS Pharmaceutics AG generate each year?
NLS Pharmaceutics AG (:NLSP) has a recorded net income of $0. NLS Pharmaceutics AG has generated $-0.32 earnings per share over the last four quarters.
-
What is NLS Pharmaceutics AG's price-to-earnings ratio?
NLS Pharmaceutics AG (:NLSP) has a price-to-earnings ratio of -79.76 and price/earnings-to-growth ratio is -0.8.
